LEGN
Legend Biotech CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.33B
P/E Ratio
—
EPS
$-1.62
Beta
0.08
52W High
$45.30
52W Low
$16.24
50-Day MA
$18.21
200-Day MA
$28.45
Dividend Yield
—
Profit Margin
-28.80%
Forward P/E
90.91
PEG Ratio
—
About Legend Biotech Corp
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally.
Fundamentals
| Revenue (TTM) | $1.03B |
| Gross Profit (TTM) | $206.10M |
| EBITDA | $-127.10M |
| Operating Margin | -6.72% |
| Return on Equity | -29.10% |
| Return on Assets | -5.01% |
| Revenue/Share (TTM) | $5.58 |
| Book Value | $5.42 |
| Price-to-Book | 3.53 |
| Price-to-Sales (TTM) | 3.23 |
| EV/Revenue | 2.921 |
| EV/EBITDA | -15.34 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 64.20% |
| Shares Outstanding | $184.96M |
| Float | $163.19M |
| % Insiders | 1.32% |
| % Institutions | 50.42% |
Analyst Ratings
Consensus ($57.22 target)
5
Strong Buy9
Buy2
HoldData last updated: 4/8/2026